Dataset from A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Subjects With Treatment Resistant Depression

The purpose of this study is to evaluate the efficacy of fixed dosed intranasal esketamine
compared to intranasal placebo, as an add-on to an oral antidepressant in Japanese
participants with treatment-resistant depression (TRD), in improving depressive symptoms.